Literature DB >> 31918012

Time Course of Inflammation in Dorsal Root Ganglia Correlates with Differential Reversibility of Mechanical Allodynia.

Myung-Chul Noh1, Benjamin Mikler1, Twinkle Joy1, Peter A Smith2.   

Abstract

Some individuals recover from the pain of nerve trauma within 12 months or less whereas others experience life-long intractable pain. This transition between reversible pain and the establishment of chronic neuropathic pain is poorly understood. We examined the role of persistent inflammation in the dorsal root ganglia (DRG) in the long-term maintenance of mechanical allodynia; an index of neuropathic pain. Male Sprague-Dawley rats underwent chronic constriction injury (CCI), spared nerve injury (SNI) or sham surgery. Both CCI and SNI animals displayed robust mechanical allodynia in the ipsilateral paw at 7 d post-surgery; however, only SNI animals maintained mechanical allodynia at 42 d post-surgery. DRGs were extracted at 7 d or 42 d post-surgery to assess inflammation via rt-qPCR or immunohistochemistry to measure colony stimulating factor 1 (CSF1) expression, satellite glial cell (SGC) activation, presence of Iba1 positive macrophages and interleukin1 β (IL-1β) mRNA levels. Whereas DRGs from SNI animals continued to display inflammatory markers at 42 d, those from CCI animals did not. Moreover, the level of allodynia displayed by each individual animal correlated with the extent of DRG inflammation. These data support the hypothesis that the amount of CSF1 immunoreactivity and the persistence of inflammation in ipsilateral DRGs contribute to the difference between transient and persistent mechanical allodynia observed in the CCI and SNI models. We also suggest that feedback loops involving cytokines and neurotransmitters may contribute to increased DRG activity in chronic neuropathic pain. Consequently, targeting persistent CSF1 production and peripheral neuroinflammation may be an effective approach to the management of chronic neuropathic pain.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  allodynia; chronic constriction injury; colony stimulating factor 1; interleukin 1 beta; neuropathic pain; spared nerves injury

Mesh:

Year:  2020        PMID: 31918012     DOI: 10.1016/j.neuroscience.2019.12.040

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

Review 1.  Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain.

Authors:  Karin N Westlund; Morgan Zhang
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

Review 2.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

Review 3.  Mediators of Neuropathic Pain; Focus on Spinal Microglia, CSF-1, BDNF, CCL21, TNF-α, Wnt Ligands, and Interleukin 1β.

Authors:  Paul A Boakye; Shao-Jun Tang; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-08-25

4.  Key role of CCR2-expressing macrophages in a mouse model of low back pain and radiculopathy.

Authors:  Li Zhang; Wenrui Xie; Jingdong Zhang; Hailey Shanahan; Raquel Tonello; Sang Hoon Lee; Judith A Strong; Temugin Berta; Jun-Ming Zhang
Journal:  Brain Behav Immun       Date:  2020-11-14       Impact factor: 7.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.